CAITLIN BRAY: Open Payments
NPI 1659713865 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 34 payments from 10 companies in 2025. Trend: 2023 $516 · 2024 $641 · 2025 $791
Food & beverage: $692Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $219 |
| Astellas Pharma US Inc | 5 | $176 |
| PFIZER INC. | 9 | $142 |
| Inspire Medical Systems, Inc. | 2 | $67 |
| Lilly USA, LLC | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Seqirus USA Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| Medtronic, Inc. | 1 | $16 |
Products named: BREZTRI, ELIQUIS, Veozah, INSPIRE, MOUNJARO, GARDASIL 9, SHINGRIX, PREVNAR 20.
Industry payments across MD — which companies pay providers there.
